MedTrace Logo

Biomarkers in Urine Samples From Patients With Wilms Tumor

NCT01550393 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2016-07-11

No results posted yet for this study

Summary

RATIONALE: Studying samples of urine from patients with cancer in the laboratory may help doctors identify biomarkers related to cancer.

PURPOSE: This clinical trial studies biomarkers in urine from patients with Wilms tumor.

Conditions

Interventions

GENETIC

proteomic profiling

OTHER

enzyme-linked immunosorbent assay

OTHER

laboratory biomarker analysis

OTHER

medical chart review

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Elizabeth A. Mullen, MD · Dana-Farber Cancer Institute

Eligibility

Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2016-07-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01550393 on ClinicalTrials.gov